Transcriptomic Insights into Polyomavirus Nephropathy in Kidney Transplants: Evaluating the Utility of the Banff Human Organ Transplant Panel
Authors:
- Kohta HatanakaKHKohta Hatanaka
- Sari IwasakiSISari Iwasaki
- Shugo TanakaSTShugo Tanaka
- Tatsu TanabeTTTatsu Tanabe
- Hajime SasakiHSHajime Sasaki
- Hiroshi HaradaHHHiroshi Harada
- Masayoshi MiuraMMMasayoshi Miura
- Daigo NakazawaDNDaigo Nakazawa
- Yasushi IshiiYIYasushi Ishii
- Takako YamaguchiTYTakako Yamaguchi
- Yuko KatayamaYKYuko Katayama
- Satoshi AoyamaSASatoshi Aoyama
- 23 October 2025
- journal article
- Published by S. Karger AG in Nephron
- Vol. 149 (Suppl. 1) , 60-69
Abstract
Background: Polyomavirus nephropathy (PyVN) is a significant complication following kidney transplantation, characterized by tubulointerstitial inflammation that mimics T-cell-mediated rejection (TCMR). The Banff Human Organ Transplant (B-HOT) panel, a transcriptomic analysis tool comprising 770 genes, has been developed to facilitate the diagnosis of allograft rejection. However, its utility in distinguishing PyVN from TCMR remains unclear. Objective: This study aimed to evaluate the biochemical characteristics of PyVN and TCMR using the B-HOT panel, investigate changes after PyVN treatment, and assess the panel’s diagnostic utility. Methods: Formalin-fixed paraffin-embedded tissue samples from 11 PyVN patients were analyzed both at diagnosis and follow-up using the B-HOT panel. Public datasets were compared to identify differentially expressed genes and activated pathways. Prognostic factors were explored based on viral clearance and renal function outcomes. Results: BK VP1 gene expression was significantly elevated in PyVN cases, aiding diagnosis. While tissue homeostasis pathways were upregulated in PyVN compared to TCMR in the original data, no specific pathways were identified in public datasets. Successful viral clearance correlated with enhanced T-cell checkpoint signaling at diagnosis, suggesting its role in immune-mediated viral elimination. Conclusion: The B-HOT panel provides limited utility for diagnosing PyVN beyond viral gene quantification. However, T-cell checkpoint signaling may serve as a prognostic marker for viral clearance and renal function preservation in PyVN cases. Further studies are needed to refine molecular diagnostics for PyVN and improve transplant outcomes.Keywords
This publication has 17 references indexed in Scilit:
- Donor Variability and PD-1 Expression Limit BK Polyomavirus-specific T-cell Function and TherapyTransplantation, 2025
- The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney TransplantationTransplantation, 2024
- Development and Validation of a Multiclass Model Defining Molecular Archetypes of Kidney Transplant Rejection: A Large Cohort Study of the Banff Human Organ Transplant Gene Expression PanelLaboratory Investigation, 2023
- Utility of Banff Human Organ Transplant Gene Panel in Human Kidney Transplant BiopsiesTransplantation, 2023
- A 2-fold Approach to Polyoma Virus (BK) Nephropathy in Kidney Transplants: Distinguishing Direct Virus Effects From Cognate T Cell–mediated InflammationTransplantation, 2021
- The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejectionAmerican Journal of Transplantation, 2020
- Generating automated kidney transplant biopsy reports combining molecular measurements with ensembles of machine learning classifiersAmerican Journal of Transplantation, 2019
- Polyomavirus BK Nephropathy-Associated Transcriptomic Signatures: A Critical ReevaluationTransplantation Direct, 2018
- Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated NephropathyTransplantation, 2016
- Quantification and identification of polyomavirus DNA in blood and urine of renal transplant recipientsDiagnostic Microbiology and Infectious Disease, 2007